All News

Amid all the excitement over recently approved immunotherapies and targeted drugs for the treatment of later-stage melanoma is an important emerging message: In many cases, two is better than one.

Survivors of testicular cancer may face an increased vulnerability to additional health problems after being treated with cisplatin-based chemotherapy.

Melanoma has been a primary focus in immunotherapy research because of intriguing evidence that some people's immune systems are better able to keep the cancer in check.

How four wise words got me through my toughest days and eventually led to a newfound awareness of life's small, precious moments.

Who could have known that leukemia would transform me from the slow, old guy to the young, fit one?

My guess is that every cancer survivor has his or her own list of negative interactions that took place while in treatment. Unfortunately, many (like me) were too knocked down by the diagnosis to stand up for their right to be treated with respect and dignity.

Recovery, like all good things, takes time. Don't short yourself.

Among undiagnosed men who took regular aspirin, the risk of developing a lethal form of prostate cancer was reduced by 24 percent.

Learn about inner strength, self-care and other helpful skills to feel better through the Reimagine Core Program.

Only 30 percent of survivors at high risk for cardiac damage adhered to long-term recommendations including an echocardiogram, electrocardiogram or multigated acquisition (MUGA) scan.

"Women with peripheral neuropathy reported significantly lower physical functioning, significantly more difficulty with tasks of daily living, and nearly twice as many of the women with neuropathy experienced a fall in the last year," says Kerri Winters-Stone.

"Low-income women tend to have less access to high-quality health care, along with unique needs and concerns," says Rose C. Maly.

David Bowie, the British singer-songwriter whose decades-spanning career was characterized by ongoing artistic reinvention, died of cancer on Sunday, Jan. 10.

The recommendation comes more than six years after sparking controversy over the need for annual mammograms.

Cometriq significantly improved progression-free survival versus Afinitor in patients with renal cell carcinoma regardless of the degree of metastases, type or number of prior treatments, or patient risk status.

In an interview with CURE, John C. Byrd discusses the efficacy of acalabrutinib and how it compares with Imbruvica.

December 10 was my New Year's Eve — it was full of hope and renewal.

There is a constellation of factors that will determine your health. Your body, mind and environment are all important variables. Here are my thoughts and what I plan to do in 2016.

A recent study has found that the majority of women at an increased risk of developing breast cancer either refuse or do not adhere to preventive treatment.

Breast cancer survivor ponders her chemo brain and her hair loss several years out from chemotherapy.

It's not always easy to keep on living when you've been told that you are dying.

To gain insight into the research needed in glioblastoma, we interviewed Robert M. Prins, an associate professor in residence at UCLA.

Recent FDA approvals have added to the growing number of treatment options for patients with advanced melanoma.

In the first days of my recovery, someone said to me, "Breast cancer in men is exceedingly rare. You're famous!"

Being a pacifist in the war on cancer stands for striving for inner peace and reducing the amount of stress associated with a life-altering illness.

I couldn't figure out how to fit in before this post. I read the blogs in the CURE community of contributors and I read the articles on the CURE home page — nothing.

In a world where cancer means loss, can letting go bring peace and joy?

Targeted drugs, as well as immunotherapies, are beginning to change the treatment outlook for people with advanced non-small cell lung cancer.